Lipella Pharmaceuticals Inc.

LIPO

Financials

10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2508/14/25 10-QQ1 ended 03/31/2505/14/25 10-KFY 202403/28/25 10-QQ3 ended 09/30/2411/14/24

Disclosures

8-KCurrent report07/15/26 8-KCurrent report03/31/26 8-KCurrent report02/04/26 8-KCurrent report10/21/25 8-KCurrent report10/09/25

Prospectuses and Registrations

424B3Prospectus04/04/25 424B5Prospectus supplement04/04/25 S-3Shelf registration03/28/25 424B3Prospectus01/16/25 S-3Shelf registration01/07/25

Proxies

PRE 14APreliminary proxy06/10/25 DEFA14AAdditional proxy materials12/20/24 DEFA14AAdditional proxy materials12/06/24 DEF 14ADefinitive proxy11/12/24 PRE 14APreliminary proxy11/01/24

Ownership

SC 13G/ABeneficial ownership (amended)05/01/25 SC 13D/ABeneficial ownership (amended)04/09/25 SC 13D/ABeneficial ownership (amended)04/09/25 Form 4Insider transaction04/07/25 SC 13D/ABeneficial ownership (amended)04/07/25

Other

25-NSERemoval from listing10/06/25 EFFECTRequest for effectiveness04/03/25 CORRESPCorrespondence with the SEC04/01/25 DD04/01/25 UPLOADLetter from the SEC03/31/25